Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil A David

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|October 3, 2018
Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral ResponsesLutz Nuhn, Stefaan De Koker, Sandra Van Lint, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR EngineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activationLutz Nuhn, Nane Vanparijs, Ans De Beuckelaer, et al.
Science Advances|September 13, 2021
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Journal of the American Chemical Society|June 12, 2020
Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug VesiclesBi Wang, Simon Van Herck, Yong Chen, et al.
Angewandte Chemie (International Ed. in English)|August 10, 2019
Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 AgonistsJana De Vrieze, Benoit Louage, Kim Deswarte, et al.
ACS Applied Materials & Interfaces|January 28, 2021
Lipid-Polyglutamate Nanoparticle Vaccine PlatformDorien Van Lysebetten, Alessio Malfanti, Kim Deswarte, et al.
ACS Nano|February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsJudith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
Angewandte Chemie (International Ed. in English)|January 19, 2021
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Microbiology Spectrum|February 16, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike AntigensClaudio Counoupas, Paco Pino, Alberto O Stella, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Advanced Materials (Deerfield Beach, Fla.)|October 3, 2018
Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral ResponsesLutz Nuhn, Stefaan De Koker, Sandra Van Lint, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR EngineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2016
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activationLutz Nuhn, Nane Vanparijs, Ans De Beuckelaer, et al.
Science Advances|September 13, 2021
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineeringJingen Zhu, Neeti Ananthaswamy, Swati Jain, et al.
Journal of the American Chemical Society|June 12, 2020
Potent and Prolonged Innate Immune Activation by Enzyme-Responsive Imidazoquinoline TLR7/8 Agonist Prodrug VesiclesBi Wang, Simon Van Herck, Yong Chen, et al.
Angewandte Chemie (International Ed. in English)|August 10, 2019
Potent Lymphatic Translocation and Spatial Control Over Innate Immune Activation by Polymer-Lipid Amphiphile Conjugates of Small-Molecule TLR7/8 AgonistsJana De Vrieze, Benoit Louage, Kim Deswarte, et al.
ACS Applied Materials & Interfaces|January 28, 2021
Lipid-Polyglutamate Nanoparticle Vaccine PlatformDorien Van Lysebetten, Alessio Malfanti, Kim Deswarte, et al.
ACS Nano|February 1, 2022
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against TumorsJudith Stickdorn, Lara Stein, Danielle Arnold-Schild, et al.
Angewandte Chemie (International Ed. in English)|January 19, 2021
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Microbiology Spectrum|February 16, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike AntigensClaudio Counoupas, Paco Pino, Alberto O Stella, et al.
Pageof 9